USE OF TOCILIZUMAB AND MESENCHYMAL STROMAL CELLS IN THE TREATMENT OF SEVERE COVID-19 - A CASE REPORT.

Autor: Senegaglia, AC¹ (AUTHOR), Rebelatto, CLK¹ (AUTHOR), Franck, CL² (AUTHOR), Lima, JS³ (AUTHOR), Daga, DR¹ (AUTHOR), Shigunov, P⁴ (AUTHOR), Azambuja, AP¹ (AUTHOR), Bana, EG³ (AUTHOR), Marsaro, DB¹ (AUTHOR), Schaidt, B¹ (AUTHOR), Micosky, A¹ (AUTHOR), Jamur, VR¹ (AUTHOR), Vaz, IM¹ (AUTHOR), Schluga, Y² (AUTHOR), Leite, LMB¹ (AUTHOR), Ribeiro, LL³ (AUTHOR), Correa, A⁴ (AUTHOR), Brofman, PRS¹ (AUTHOR)

Publikováno v: Cytotherapy (Elsevier Inc.). Apr2021 Supplement, Vol. 23, p38-39. 2p.